Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
35.03
-0.26 (-0.74%)
At close: Jan 22, 2026, 4:00 PM EST
35.03
0.00 (0.00%)
After-hours: Jan 22, 2026, 6:10 PM EST
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.77 billion as of January 22, 2026. Its market cap has increased by 18.48% in one year.
Market Cap
1.77B
Enterprise Value
1.31B
1-Year Change
18.48%
Ranking
Category
Stock Price
$35.03
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.77B, a decrease of -1.44%. That is a compound annual growth rate of -0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.78B | 1.67% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | 1.80B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.85B |
| Sionna Therapeutics | 1.82B |
| Zymeworks | 1.79B |
| Pharvaris | 1.79B |
| Syndax Pharmaceuticals | 1.78B |
| MannKind | 1.75B |
| Celldex Therapeutics | 1.74B |
| Biohaven | 1.71B |